Pacira Pharm Inc (PCRX)
18.51 x 1 29.49 x 2
Post-market by (Cboe BZX)
24.91 -0.39 (-1.54%) 03/28/25 [NASDAQ]
18.51 x 1 29.49 x 2
Post-market 24.91 unch (unch) 16:02 ET
for Fri, Mar 28th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -99,560 | 41,955 | 15,909 | 41,980 | 145,523 |
Depreciation Amortization | 82,007 | 79,322 | 98,708 | 54,454 | 40,318 |
Income taxes - deferred | 20,621 | 15,615 | -7,945 | 10,872 | -126,613 |
Accounts receivable | -7,748 | -7,159 | -2,079 | -10,434 | -5,516 |
Accounts payable and accrued liabilities | 3,084 | 916 | 6,272 | -10,262 | -3,312 |
Other Working Capital | -18,519 | -45,777 | -16,433 | -25,509 | -19,182 |
Other Operating Activity | 209,504 | 69,777 | 50,842 | 64,616 | 45,814 |
Operating Cash Flow | $189,389 | $154,649 | $145,274 | $125,717 | $77,032 |
Cash Flows From Investing Activities | |||||
Change In Deposits | N/A | -6,758 | -13,000 | -17,187 | -1,160 |
PPE Investments | -10,636 | -15,161 | -30,076 | -45,866 | -37,801 |
Net Acquisitions | N/A | N/A | -32,000 | -424,042 | N/A |
Purchase Of Investment | -252,212 | -137,608 | -387,685 | -602,431 | -546,516 |
Sale Of Investment | 179,572 | 237,068 | 237,576 | 1,068,736 | 307,870 |
Investing Cash Flow | $-83,276 | $77,541 | $-225,185 | $-20,790 | $-277,607 |
Cash Flows From Financing Activities | |||||
Debt Issued | N/A | 149,550 | N/A | 363,750 | 402,500 |
Debt Repayment | 76,615 | -330,312 | -427,694 | N/A | -209,882 |
Common Stock Issued | 2,298 | 4,750 | 27,341 | 26,655 | 47,764 |
Common Stock Repurchased | -25,000 | N/A | N/A | N/A | N/A |
Other Financing Activity | -36,550 | -7,019 | -1,175 | -9,711 | -18,078 |
Financing Cash Flow | $17,363 | $-183,031 | $-401,528 | $380,694 | $222,304 |
Beginning Cash Position | 153,298 | 104,139 | 585,578 | 99,957 | 78,228 |
End Cash Position | 276,774 | 153,298 | 104,139 | 585,578 | 99,957 |
Net Cash Flow | $123,476 | $49,159 | $-481,439 | $485,621 | $21,729 |
Free Cash Flow | |||||
Operating Cash Flow | 189,389 | 154,649 | 145,274 | 125,717 | 77,032 |
Capital Expenditure | -10,636 | -15,161 | -30,076 | -45,866 | -37,801 |
Free Cash Flow | 178,753 | 139,488 | 115,198 | 79,851 | 39,231 |